Tilray Brands to acquire HelloMD Canadian medical cannabis assets after court approval

Tilray Brands

TLRY

0.00

Tilray Brands agreed to acquire HelloMD’s Canadian medical cannabis assets, a digital healthcare and patient engagement platform, following a formal sale process.
Deal aims to expand direct-to-patient access in Canada, strengthening telehealth consultations, education, and engagement across the medical cannabis care journey.
Transaction is expected to create a vertically integrated Canadian medical cannabis model linking cultivation, clinical support, product access, and fulfillment.
HelloMD has supported hundreds of thousands of patients through telehealth consultations and personalized medical cannabis guidance.
Financial terms were not disclosed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tilray Brands Inc. published the original content used to generate this news brief on June 29, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.